Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Arzneimittel-Forschung
|
January 1, 1977
[Development of new antiepileptics. II. Anticonvulsant effect of hydantoin derivatives]
P G Waser, A J Ganz, R W Pfirrmann
Arzneimittel-Forschung
|
January 1, 1977
[Anticovulsant activity of N-(p-sulfamoyl-phenyl)-succinimide derivatives (author's transl)]
P G Waser, A J Ganz, R W Pfirrmann
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes
|
December 18, 2008
Wound healing is not impaired in rats undergoing perioperative treatment with the antineoplastic agent taurolidine
C Braumann, N Guenther, J Pohlenz, et al.
British Journal of Clinical Pharmacology
|
September 1, 1981
The characterisation and quantitation by high-performance liquid chromatography of the metabolites of taurolin
B I Knight, G G Skellern, M K Browne, et al.
British Journal of Clinical Pharmacology
|
November 1, 1981
Peritoneal absorption of the antibacterial and antiendotoxin taurolin in peritonitis
B I Knight, G G Skellern, M K Browne, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes
|
February 28, 2008
Leukopoiesis is not affected after intravenous treatment with the novel antineoplastic agent taurolidine. Results of an experimental study in rats
C Braumann, C Menenakos, V Atanassov, et al.
Journal of Pharmaceutical Sciences
|
June 1, 1983
NMR studies and GC analysis of the antibacterial agent taurolidine
B I Knight, G G Skellern, G A Smail, et al.
Talanta
|
January 1, 1994
Studies of the thiadiazine, taurolidine-I. Identification of the molecular species present in aqueous solutions by (1)H- and (13)C-NMR spectroscopy
H T Hood, G A Smail, G G Skellern, et al.
BMC Cancer
|
March 26, 2017
Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo
M Buchholz, B Majchrzak-Stiller, S Hahn, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Arzneimittel-Forschung
|
January 1, 1977
[Development of new antiepileptics. II. Anticonvulsant effect of hydantoin derivatives]
P G Waser, A J Ganz, R W Pfirrmann
Arzneimittel-Forschung
|
January 1, 1977
[Anticovulsant activity of N-(p-sulfamoyl-phenyl)-succinimide derivatives (author's transl)]
P G Waser, A J Ganz, R W Pfirrmann
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes
|
December 18, 2008
Wound healing is not impaired in rats undergoing perioperative treatment with the antineoplastic agent taurolidine
C Braumann, N Guenther, J Pohlenz, et al.
British Journal of Clinical Pharmacology
|
September 1, 1981
The characterisation and quantitation by high-performance liquid chromatography of the metabolites of taurolin
B I Knight, G G Skellern, M K Browne, et al.
British Journal of Clinical Pharmacology
|
November 1, 1981
Peritoneal absorption of the antibacterial and antiendotoxin taurolin in peritonitis
B I Knight, G G Skellern, M K Browne, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes
|
February 28, 2008
Leukopoiesis is not affected after intravenous treatment with the novel antineoplastic agent taurolidine. Results of an experimental study in rats
C Braumann, C Menenakos, V Atanassov, et al.
Journal of Pharmaceutical Sciences
|
June 1, 1983
NMR studies and GC analysis of the antibacterial agent taurolidine
B I Knight, G G Skellern, G A Smail, et al.
Talanta
|
January 1, 1994
Studies of the thiadiazine, taurolidine-I. Identification of the molecular species present in aqueous solutions by (1)H- and (13)C-NMR spectroscopy
H T Hood, G A Smail, G G Skellern, et al.
BMC Cancer
|
March 26, 2017
Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo
M Buchholz, B Majchrzak-Stiller, S Hahn, et al.
Page
of 2